Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2 Meeting Abstract


Authors: Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Krug, L. M.; Bekele, S.; Dowlati, A.; Rowland, K. M.; Salgia, R.; Aggarwal, N.; Gadgeel, S. M.
Abstract Title: Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 437s
Language: English
ACCESSION: WOS:000208457402802
PROVIDER: wos
DOI: 10.1200/jco.2008.26.15_suppl.8053
Notes: Meeting Abstract: 8053 -- Source: Wos
Altmetric Score
MSK Authors
  1. Lee M Krug
    210 Krug
  2. Naiyer A Rizvi
    155 Rizvi
  3. Vincent Miller
    259 Miller
  4. Mark Kris
    597 Kris
  5. Sara Bekele
    7 Bekele